Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Holland GN . Standard diagnostic criteria for the acute retinal necrosis syndrome. Am J Ophthalmol 1994; 117: 663–667.
Martin DF, Sierra-Madero J, Walmsley S, Wolit RA, Racey K, Georgion P . A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med 2002; 346: 1119–1126.
Lalezari J, Lindley J, Walmsley S, Kuppermann B, Fisher R, Friedberg D . A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis. J Acquir Immune Defic Syndr 2002; 30: 392–400.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Savant, V., Saeed, T., Denniston, A. et al. Oral valganciclovir treatment of varicella zoster virus acute retinal necrosis. Eye 18, 544–545 (2004). https://doi.org/10.1038/sj.eye.6700703
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6700703
This article is cited by
-
Valacyclovir in the treatment of acute retinal necrosis
BMC Ophthalmology (2012)
-
Akute retinale Nekrose aus Virologensicht
Der Ophthalmologe (2009)
-
High dosage of oral valaciclovir as an alternative treatment of varicella zoster acute retinal necrosis syndrome
Eye (2006)
